Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness

Table 4

Different dosage and schedules of low-dose cytarabine.

	Baccarani and Tura [10]	Moloney and Rosenthal [11]	Weh et al. [17]	Kantarjian et al. [13]	Bashir et al. [14]	Present study
Dose of cytarabine	10 mg/m^2 12 hourly for 21 days	10 mg/m^2 12 hourly for 15 days	10 mg/m^2 12 hourly for 14–28 days	20 mg/m^2 once a day for 10 days	20 mg/m^2 12 hourly for 4 days/week	20 mg/m^2 once a day for 10 days
Overall survival (range)				5 months	18 months; (3–24 months)	5.5 months (0.5–17.1 months)